These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 23821273)

  • 1. Expression and purification of dengue virus NS5 polymerase and development of a high-throughput enzymatic assay for screening inhibitors of dengue polymerase.
    Gong EY; Kenens H; Ivens T; Dockx K; Vermeiren K; Vandercruyssen G; Devogelaere B; Lory P; Kraus G
    Methods Mol Biol; 2013; 1030():237-47. PubMed ID: 23821273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of specific dengue virus 2'-O- and N7-methyltransferase assays for antiviral drug screening.
    Barral K; Sallamand C; Petzold C; Coutard B; Collet A; Thillier Y; Zimmermann J; Vasseur JJ; Canard B; Rohayem J; Debart F; Decroly E
    Antiviral Res; 2013 Sep; 99(3):292-300. PubMed ID: 23769894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of plasmid, bacterial expression, purification, and assay of dengue virus type 2 NS5 methyltransferase.
    Boonyasuppayakorn S; Padmanabhan R
    Methods Mol Biol; 2014; 1138():361-73. PubMed ID: 24696348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stabilization of dengue virus polymerase in de novo initiation assay provides advantages for compound screening.
    Niyomrattanakit P; Wan KF; Chung KY; Abas SN; Seh CC; Dong H; Lim CC; Chao AT; Lee CB; Nilar S; Lescar J; Shi PY; Beer D; Lim SP
    Antiviral Res; 2015 Jul; 119():36-46. PubMed ID: 25896272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of robust in vitro RNA-dependent RNA polymerase assay as a possible platform for antiviral drug testing against dengue.
    Amraiz D; Zaidi NU; Fatima M
    Enzyme Microb Technol; 2016 Oct; 92():26-30. PubMed ID: 27542741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two RNA Tunnel Inhibitors Bind in Highly Conserved Sites in Dengue Virus NS5 Polymerase: Structural and Functional Studies.
    Arora R; Liew CW; Soh TS; Otoo DA; Seh CC; Yue K; Nilar S; Wang G; Yokokawa F; Noble CG; Chen YL; Shi PY; Lescar J; Smith TM; Benson TE; Lim SP
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32907977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dengue virus NS5 protein as a target for drug discovery.
    Lim SP; Noble CG; Shi PY
    Antiviral Res; 2015 Jul; 119():57-67. PubMed ID: 25912817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationship study of biflavonoids on the Dengue virus polymerase DENV-NS5 RdRp.
    Coulerie P; Nour M; Maciuk A; Eydoux C; Guillemot JC; Lebouvier N; Hnawia E; Leblanc K; Lewin G; Canard B; Figadère B
    Planta Med; 2013 Sep; 79(14):1313-8. PubMed ID: 23929244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Looking for inhibitors of the dengue virus NS5 RNA-dependent RNA-polymerase using a molecular docking approach.
    Galiano V; Garcia-Valtanen P; Micol V; Encinar JA
    Drug Des Devel Ther; 2016; 10():3163-3181. PubMed ID: 27784988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-based antiviral assays for screening and profiling inhibitors against dengue virus.
    Gong EY; Clynhens M; Ivens T; Lory P; Simmen K; Kraus G
    Methods Mol Biol; 2013; 1030():185-94. PubMed ID: 23821269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a Pyridoxine-Derived Small-Molecule Inhibitor Targeting Dengue Virus RNA-Dependent RNA Polymerase.
    Xu HT; Colby-Germinario SP; Hassounah S; Quashie PK; Han Y; Oliveira M; Stranix BR; Wainberg MA
    Antimicrob Agents Chemother; 2016 Jan; 60(1):600-8. PubMed ID: 26574011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying initiation and elongation inhibitors of dengue virus RNA polymerase in a high-throughput lead-finding campaign.
    Smith TM; Lim SP; Yue K; Busby SA; Arora R; Seh CC; Wright SK; Nutiu R; Niyomrattanakit P; Wan KF; Beer D; Shi PY; Benson TE
    J Biomol Screen; 2015 Jan; 20(1):153-63. PubMed ID: 25252731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and characterization of a stable luciferase dengue virus for high-throughput screening.
    Zou G; Xu HY; Qing M; Wang QY; Shi PY
    Antiviral Res; 2011 Jul; 91(1):11-9. PubMed ID: 21575658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-based and ligand-based virtual screening of novel methyltransferase inhibitors of the dengue virus.
    Lim SV; Rahman MB; Tejo BA
    BMC Bioinformatics; 2011; 12 Suppl 13(Suppl 13):S24. PubMed ID: 22373153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Narasin, a novel antiviral compound that blocks dengue virus protein expression.
    Low JS; Wu KX; Chen KC; Ng MM; Chu JJ
    Antivir Ther; 2011; 16(8):1203-18. PubMed ID: 22155902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biflavonoids of Dacrydium balansae with potent inhibitory activity on dengue 2 NS5 polymerase.
    Coulerie P; Eydoux C; Hnawia E; Stuhl L; Maciuk A; Lebouvier N; Canard B; Figadère B; Guillemot JC; Nour M
    Planta Med; 2012 May; 78(7):672-7. PubMed ID: 22411725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel inhibitor of dengue virus protease through use of a virtual screening drug discovery Web portal.
    Viswanathan U; Tomlinson SM; Fonner JM; Mock SA; Watowich SJ
    J Chem Inf Model; 2014 Oct; 54(10):2816-25. PubMed ID: 25263519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent Allosteric Dengue Virus NS5 Polymerase Inhibitors: Mechanism of Action and Resistance Profiling.
    Lim SP; Noble CG; Seh CC; Soh TS; El Sahili A; Chan GK; Lescar J; Arora R; Benson T; Nilar S; Manjunatha U; Wan KF; Dong H; Xie X; Shi PY; Yokokawa F
    PLoS Pathog; 2016 Aug; 12(8):e1005737. PubMed ID: 27500641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant DENV 2 NS5: An effective antigen for diagnosis of DENV infection.
    Zhang T; Wang ML; Zhang GR; Liu W; Xiao XQ; Yang YS; Li JT; Xun ZM; Li DY; Chan PKS
    J Virol Methods; 2019 Mar; 265():35-41. PubMed ID: 30562608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant dengue type 1 virus NS5 protein expressed in Escherichia coli exhibits RNA-dependent RNA polymerase activity.
    Tan BH; Fu J; Sugrue RJ; Yap EH; Chan YC; Tan YH
    Virology; 1996 Feb; 216(2):317-25. PubMed ID: 8607261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.